Biggest News Aggregation in the World
📰 Clinical Development News

Page 69 - Clinical Development News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clinical Development. Real-time updates on events, politics, business and more.

Inventiva announces a late breaker abstract and two additional abstracts on its lead compound, lanifibranor, at the AASLD The Liver Meeting® 2023

The phase II study led by Dr. Kenneth Cusi evaluating lanifibranor in patients with T2D and MASLD was selected as late breaker.Two additional scientific abstracts from the NATIVE Phase IIb clinical trial evaluating lanifibranor for the treatment of patients with NASH have been selected for presentation. The two abstracts show: the correlation between the increase of adiponectin under lanifibranor and the improvement of histological and serum markers of NASH severity both in terms of activity and
Israel General United States New York Martine Baudin Louis Griffel Jean Louis Junien
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U.S. Study

Boehringer Ingelheim and Carelon Research have conducted the first large-scale U.S. validation of a new AI-driven tool for chronic kidney disease (CKD) The Klinrisk model predicted disease progression in over 80% of individuals at all stages of the disease, based on data from a diverse population of over 4 million U.S. adults Validated tools to […]
United States Rheinland Pfalz Navdeep Tangri Mohamed Eid Mark Cziraky Carelon Research

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science